Table 4

 Drug related adverse events

Infliximab + MTX group (n = 28)Placebo + MTX group (n = 14)
Values are number of patients experiencing at least one episode of adverse event for each category.
*Both events were felt to be more related to methotrexate than infliximab. Oral thrush settled with increase in folic and topical treatment. In one patient transaminases settled after a transient reduction in the MTX dose.
Minor infections:
    Upper respiratory tract22
    Sore throat10
    Oral thrush1*0
Transient rise in transaminases2*0
Chest infection10
Urticarial rash10
Infusion reactions10
Total, No (%)13 (46)2 (14)